or Try an Advanced Search...

    Technical Analysis for AEON - AEON Biopharma, Inc.

    Grade Last Price % Change Price Change
    F 1.04 -0.95% -0.01
    AEON closed down 0.95 percent on Monday, July 1, 2024, on 48 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical AEON trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Hammer Candlestick Bullish -0.95%
    Lizard Bullish Bullish Day Trade Setup -0.95%
    New 52 Week Low Weakness -0.95%
    Wide Bands Range Expansion -0.95%
    Oversold Stochastic Weakness -0.95%
    NR7 Range Contraction -1.89%
    NR7-2 Range Contraction -1.89%
    Narrow Range Bar Range Contraction -1.89%
    Older End-of-Day Signals for AEON ...

       Recent Intraday Alerts

    Alert Time
    Lizard Bullish Entry about 7 hours ago
    Hammer Candlestick Entry about 7 hours ago
    Rose Above Previous Day's High about 7 hours ago
    Down 5% about 7 hours ago
    Down 3% about 7 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    AEON Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Botulinum Toxin Dystonia

    Is AEON a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 29 Down -64.16% in 4 Weeks, Here's Why AEON Biopharma, Inc. (AEON) Looks Ripe for a Turnaround
    May 29 AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan
    May 15 AEON Biopharma, Inc. GAAP EPS of -$3.17
    May 14 AEON Biopharma Reports First Quarter 2024 Financial Results
    May 9 AEON Biopharma, Inc. (AEON) Loses -79.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
    May 9 AEON Biopharma Provides Update on Development Pipeline
    May 3 US Equity Markets Close Higher Friday Following Weak Jobs Report
    May 3 Newly Listed Migraine-Focused AEON Biopharma Stock Plunges On Friday - Read Here Why
    May 3 AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine
    Apr 19 Here's Why AEON Biopharma, Inc. (AEON) Is a Great 'Buy the Bottom' Stock Now
    See more AEON news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.17
    52 Week Low 0.9176
    Average Volume 97,516
    200-Day Moving Average 6.23
    50-Day Moving Average 2.03
    20-Day Moving Average 1.34
    10-Day Moving Average 1.15
    Average True Range 0.22
    RSI (14) 31.97
    ADX 30.22
    +DI 13.57
    -DI 27.85
    Chandelier Exit (Long, 3 ATRs) 1.13
    Chandelier Exit (Short, 3 ATRs) 1.59
    Upper Bollinger Bands 1.81
    Lower Bollinger Band 0.87
    Percent B (%b) 0.18
    BandWidth 70.63
    MACD Line -0.37
    MACD Signal Line -0.43
    MACD Histogram 0.0621
    Fundamentals Value
    Market Cap 38.65 Million
    Num Shares 37.2 Million
    EPS -2.39
    Price-to-Earnings (P/E) Ratio -0.44
    Price-to-Sales 97.16
    Price-to-Book 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.24
    Resistance 3 (R3) 1.24 1.17 1.21
    Resistance 2 (R2) 1.17 1.12 1.17 1.20
    Resistance 1 (R1) 1.10 1.09 1.07 1.11 1.18
    Pivot Point 1.04 1.04 1.02 1.04 1.04
    Support 1 (S1) 0.97 0.98 0.94 0.97 0.90
    Support 2 (S2) 0.90 0.95 0.90 0.88
    Support 3 (S3) 0.84 0.90 0.87
    Support 4 (S4) 0.84